A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141

出版年份 2017 全文链接

标题

作者

关键词

Nivolumab, Squamous cell carcinoma of the head and neck, Programmed death-1, Asian

出版物

ORAL ONCOLOGY

Volume 73, Issue -, Pages 138-146

出版商

Elsevier BV

发表日期

2017-09-02

DOI

10.1016/j.oraloncology.2017.07.023

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.